CONMED (CNMD) Stock Price, News & Analysis

-1.44 (-2.02%)
(As of 04/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.19 million shs
Average Volume
430,156 shs
Market Capitalization
$2.15 billion
P/E Ratio
Dividend Yield
Price Target

CONMED MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
72.3% Upside
$120.43 Price Target
Short Interest
13.22% of Shares Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.44mentions of CONMED in the last 14 days
Based on 20 Articles This Week
Insider Trading
Proj. Earnings Growth
From $4.34 to $5.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.83 out of 5 stars

Medical Sector

43rd out of 907 stocks

Electromedical Equipment Industry

1st out of 19 stocks

CNMD stock logo


CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

CNMD Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Conmed: Q1 Earnings Snapshot
Conmed Corp. Q1 Income Climbs, but misses estimates
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Conmed is about to announce its earnings — here's what to expect
CONMED (NYSE:CNMD) Reaches New 12-Month Low at $71.25
CONMED (CNMD) Scheduled to Post Earnings on Wednesday
Should You Invest in CONMED (CNMD)?
3 Retirement Stocks to Buy at a 52-Week Low in March
CNMD Apr 2024 120.000 call
CNMD Apr 2024 90.000 put
CONMED Corporation declares $0.20 dividend
CONMED Corporation Announces Quarterly Cash Dividend
CNMD Mar 2024 80.000 call
CNMD Mar 2024 80.000 put
CNMD Mar 2024 105.000 call
See More Headlines
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 4/5 Dividend
Dividend Payable
Fiscal Year End

Industry, Sector and Symbol

Electromedical equipment
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
$64.46 million
Pretax Margin


Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$5.83 per share
Book Value
$27.13 per share


Free Float
Market Cap
$2.15 billion
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

CNMD Stock Analysis - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price target for 2024?

7 brokerages have issued twelve-month target prices for CONMED's shares. Their CNMD share price targets range from $98.00 to $141.00. On average, they anticipate the company's share price to reach $120.43 in the next year. This suggests a possible upside of 72.3% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2024?

CONMED's stock was trading at $109.51 on January 1st, 2024. Since then, CNMD shares have decreased by 36.2% and is now trading at $69.8750.
View the best growth stocks for 2024 here

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) posted its quarterly earnings data on Wednesday, April, 24th. The company reported $0.79 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.05. The firm had revenue of $312.27 million for the quarter, compared to the consensus estimate of $307.06 million. CONMED had a net margin of 5.18% and a trailing twelve-month return on equity of 13.69%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Monday, February 26th. Stockholders of record on Friday, March 15th will be given a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Thursday, March 14th.
Read our dividend analysis for CNMD

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.12%. The dividend payout ratio is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.11% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.

What ETFs hold CONMED's stock?
What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY 2024 earnings guidance on Wednesday, April, 24th. The company provided EPS guidance of 4.250-4.350 for the period, compared to the consensus earnings per share estimate of 4.330. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are CONMED's major shareholders?

CONMED's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Mountain Pacific Investment Advisers Inc. ID (0.81%), Portman Square Capital LLP (0.00%), Raymond James & Associates (0.27%), AMI Asset Management Corp (0.18%), State of Alaska Department of Revenue (0.06%) and Fifth Third Bancorp (0.06%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners